Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zentalis Pharmaceuticals, Inc. | Director | Common Stock | 79.8K | $956K | $11.98 | Jun 21, 2024 | Direct |
Imago BioSciences, Inc. | Director | Stock Option (Right to Buy) | 0 | Jan 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ZNTL | Zentalis Pharmaceuticals, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
ZNTL | Zentalis Pharmaceuticals, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
IMGO | Imago BioSciences, Inc. | Jan 11, 2023 | 3 | $0 | 4 | Jan 11, 2023 | Director |
ZNTL | Zentalis Pharmaceuticals, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
IMGO | Imago BioSciences, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
IMGO | Imago BioSciences, Inc. | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |
IMGO | Imago BioSciences, Inc. | Jul 15, 2021 | 0 | $0 | 3 | Jul 15, 2021 | Director |